Today's Research. Tomorrow's Cure. ™
The NCC Research Fund fulfills two institutional grant-making objectives - Seeding and Bridging.
We provide seeding funds for our scientists to help them kick-start their research projects. By so doing, they build a track record and would be able to apply for sustainable competitive grants from government agencies.
Furthermore, we enable our scientists to work with productive momentum by providing bridging funds between government grant cycles when the need arises.
We firmly believe that today’s research will pave the way for a cure for cancer tomorrow.
NCCRF is registered under the Charities Act as an Institution of Public Character (IPC) with an independent Board of Trustees. All donations to the NCCRF are eligible for double tax exemption.
Financial Information
Click here to view Financial Information
Charity Status
Charity Registration No.: 01897
Charity Registration Date: 8.19.2005
Gov. Instrument: Rules & Regulations
ROS Registration No.: Not Applicable
Date of Establishment: 5.6.2005
PC Status
Effective Date: 8.19.2005 – 8.18.2008
Member of Central Fund: Health Endowment Fund
NCC Research Fund Board of Trustees
Chairman
Dr Charles Toh
Consultant Cardiologist, Charles Toh Clinic
Members
Prof Tan Ser Kiat
Group Chief Executive Officer, Singapore Health Services
Prof Soo Khee Chee
Director, National Cancer Centre Singapore
Mr Lee Kim Shin
Partner, Allen & Gledhill, Advocates & Solicitors
Mr Ng Boon Yew
Chairman, Raffles Campus Pte Ltd
Mr Tan Ng Kuang Nicky
Director, Ntan Corporate Advisory Pte Ltd
Investment Committee
Chairman
Mr Tan Ng Kuang Nicky
Director, Ntan Corporate Advisory Pte Ltd
Members
Dr Charles Toh
Consultant Cardiologist, Charles Toh Clinic
Mr Ng Boon Yew
Chairman, Raffles Campus Pte Ltd
NCC Scientific Advisory Board
Prof Kie-Kian Ang
Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Centre
Prof Arnold J Levine
Institute of Advanced Study, Princeton
Prof Alan P Venook
Division of Medical Oncology, University of California, San Francisco
Auditor
Ernst & Young |